Literature DB >> 10216059

Natural history of amblyopia untreated owing to lack of compliance.

K Simons1, M Preslan.   

Abstract

AIMS: A prospective study of the efficacy of amblyopia treatment in preschool children has recently been called for, requiring an untreated control group. The present study assessed data from patients with amblyopia untreated owing to lack of compliance, or with amblyopia risk factors, to determine outcome.
METHODS: Longitudinal data were obtained from 18 4-6 year old patients who had initially been screened for amblyopia, strabismus, and/or bilateral refractive error, failed to comply with prescribed treatment, and in whom amblyopia was detected at a rescreening approximately a year later. The data from three previous studies comparing outcome of patients compliant and non-compliant with amblyopia treatment were also reanalysed.
RESULTS: One child of the 18, who wore glasses sporadically, showed some improvement in visual acuity in the amblyopic eye. Otherwise, no child showed an improvement, and seven of the 17 (41%) for whom visual acuities were available at both screenings showed a deterioration of visual acuity in the amblyopic eye, including three who apparently developed amblyopia for the first time. A child with an ametropic risk factor for amblyopia whose visual acuity was not obtained at the first screening and who was largely non-compliant presented with amblyopia at the second screening. The reanalysed data from the three previous studies demonstrated a significantly poorer visual acuity outcome in the amblyopic eye in the non-compliant patient groups than in the compliant groups in each study.
CONCLUSION: Preschool children with amblyopia or its risk factors are at risk of having the current amblyopia deteriorate, or of developing amblyopia, if not treated. These results raise questions about the ethical acceptability of a prospective study of amblyopia treatment at these ages.

Entities:  

Mesh:

Year:  1999        PMID: 10216059      PMCID: PMC1723047          DOI: 10.1136/bjo.83.5.582

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  35 in total

1.  Do we have optimal screening limits in Sweden for vision testing at the age of 4 years?

Authors:  A L Hård; P Williams; J Sjöstrand
Journal:  Acta Ophthalmol Scand       Date:  1995-12

2.  Two infant vision screening programmes: prediction and prevention of strabismus and amblyopia from photo- and videorefractive screening.

Authors:  J Atkinson; O Braddick; B Robier; S Anker; D Ehrlich; J King; P Watson; A Moore
Journal:  Eye (Lond)       Date:  1996       Impact factor: 3.775

3.  Baltimore Vision Screening Project.

Authors:  M W Preslan; A Novak
Journal:  Ophthalmology       Date:  1996-01       Impact factor: 12.079

4.  Monocular visual outcome in untreated early onset esotropia.

Authors:  W V Good; L C da Sa; C J Lyons; C S Hoyt
Journal:  Br J Ophthalmol       Date:  1993-08       Impact factor: 4.638

5.  Factors affecting long term results of successfully treated amblyopia: initial visual acuity and type of amblyopia.

Authors:  S Levartovsky; M Oliver; N Gottesman; M Shimshoni
Journal:  Br J Ophthalmol       Date:  1995-03       Impact factor: 4.638

Review 6.  Preschool vision screening: rationale, methodology and outcome.

Authors:  K Simons
Journal:  Surv Ophthalmol       Date:  1996 Jul-Aug       Impact factor: 6.048

Review 7.  Screening for ocular dysfunction in children: approaching a common program.

Authors:  G Lennerstrand; P Jakobsson; G Kvarnström
Journal:  Acta Ophthalmol Scand Suppl       Date:  1995

8.  Assessment of an inner city visual screening programme for preschool children.

Authors:  T H Williamson; R Andrews; G N Dutton; G Murray; N Graham
Journal:  Br J Ophthalmol       Date:  1995-12       Impact factor: 4.638

9.  Artifacts in fusion and stereopsis testing based on red/green dichoptic image separation.

Authors:  K Simons; K Elhatton
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1994 Sep-Oct       Impact factor: 1.402

10.  Upper age limit for the development of amblyopia.

Authors:  R V Keech; P J Kutschke
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1995 Mar-Apr       Impact factor: 1.402

View more
  30 in total

1.  Amblyopia therapy.

Authors:  B W Fleck
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

2.  Efficacy of occlusion for strabismic amblyopia: can an optimal duration be identified?

Authors:  M Cleary
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

3.  Treatment of unilateral visual impairment on preschool vision screening: preschool vision screening should continue, perhaps earlier.

Authors:  Gerard O'Brien
Journal:  BMJ       Date:  2004-02-07

4.  Conventional occlusion versus pharmacologic penalization for amblyopia.

Authors:  Tianjing Li; Riaz Qureshi; Kate Taylor
Journal:  Cochrane Database Syst Rev       Date:  2019-08-28

5.  Long term visual outcome in amblyopia treatment.

Authors:  J Ohlsson; M Baumann; J Sjöstrand; M Abrahamsson
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

6.  Amblyopia therapy in Asian children: factors affecting visual outcome and parents' perception of children's attitudes towards amblyopia treatment.

Authors:  Swati Handa; Audrey Chia
Journal:  Singapore Med J       Date:  2018-11-29       Impact factor: 1.858

7.  Prevalence of amblyopia and strabismus in African American and Hispanic children ages 6 to 72 months the multi-ethnic pediatric eye disease study.

Authors: 
Journal:  Ophthalmology       Date:  2007-10-22       Impact factor: 12.079

8.  Why is compliance with occlusion therapy for amblyopia so hard? A qualitative study.

Authors:  M Dixon-Woods; M Awan; I Gottlob
Journal:  Arch Dis Child       Date:  2006-03-10       Impact factor: 3.791

9.  Current concepts in the management of amblyopia.

Authors:  Blanca Ruiz de Zárate; Jaime Tejedor
Journal:  Clin Ophthalmol       Date:  2007-12

10.  Compliance of amblyopic patients with occlusion therapy: A pilot study.

Authors:  Sana Al-Zuhaibi; Iman Al-Harthi; Pascale Cooymans; Aisha Al-Busaidi; Yahya Al-Farsi; Anuradha Ganesh
Journal:  Oman J Ophthalmol       Date:  2009-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.